Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rett syndrome: a prototypical neurodevelopmental disorder.

Jeffrey L Neul1, Huda Y Zoghbi

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|April 9, 2004
PubMed
Summary

Rett syndrome, a developmental disorder, is caused by mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. Research shows MeCP2 mutations have a wider impact than previously thought, affecting various neurodevelopmental conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-nucleus profiling reveals a core disease signature and cell type-specific vulnerabilities in early Rett syndrome.

Science advances·2026
Same author

Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson's disease mouse model.

bioRxiv : the preprint server for biology·2026
Same author

Publisher Correction: Presymptomatic training mitigates functional deficits in a mouse model of Rett syndrome.

Nature·2026
Same author

Transcriptomic data and biomedical literature synergize in finding pharmacologic gene regulators.

bioRxiv : the preprint server for biology·2026
Same author

Trajectory of skill acquisition, loss, and regain in females with classic Rett syndrome.

Journal of neurodevelopmental disorders·2026
Same author

Modulating alternative splicing of <i>MECP2</i> is a potential therapeutic strategy for Rett syndrome.

Science translational medicine·2026

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • Rett syndrome is a primary cause of developmental regression in girls.
  • It is the first pervasive developmental disorder with an identified genetic cause.
  • Mutations in the methyl-CpG-binding protein 2 (MeCP2) gene are responsible for most sporadic Rett syndrome cases.

Purpose of the Study:

  • To investigate the role of MeCP2 in gene regulation and chromatin structure.
  • To analyze the genotype/phenotype spectrum of MECP2 mutations in humans.
  • To explore the potential common pathogenic mechanisms underlying Rett syndrome and other neurodevelopmental disorders.

Main Methods:

  • Genotype/phenotype analysis in human subjects.
  • Development of in vivo and in vitro models for MeCP2 function studies.

Related Experiment Videos

  • Comparative analysis of neuropathological features across neurodevelopmental disorders.

    • Main Results:

    • MeCP2 binds methylated DNA and influences gene expression and chromatin structure.
    • MECP2 mutations are associated with a broader range of conditions than initially recognized, including Rett syndrome variants, mentally retarded males, and autistic children.
    • Established models facilitate the study of MeCP2 function and Rett syndrome pathogenesis.

    Conclusions:

    • Rett syndrome serves as a model for understanding the genetic, molecular, and neurobiological aspects of neurodevelopmental disorders.
    • The findings suggest shared pathogenic processes may link Rett syndrome with other neurodevelopmental conditions.
    • Further research into MeCP2 function can provide insights into a spectrum of neurodevelopmental disorders.